7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Septic shock is a life-threatening condition that occurs when the blood pressure drops to a low level after an infection. Atrial fibrillation (AF) is the most common arrhythmia to complicate its course. Beta (β)-blockers are often administrated to manage supraventricular tachyarrhythmias observed in patients presenting with sepsis. A 74-year-old woman presenting with sepsis demonstrated AF tachycardia characterised by severe hypotension. She was refractory to conventional therapy including verapamil and digoxin; therefore, treatment using landiolol (an ultrashort-acting β-blocker) was initiated. Her clinical course was followed over 48 hours, and she showed a significant improvement in her heart rate and blood pressure without any adverse effect. Landiolol can rapidly control the accelerated heart rate associated with AF in critically decompensated patients presenting with septic shock.

          Related collections

          Author and article information

          Journal
          BMJ Case Rep
          BMJ Case Rep
          casereports
          bmjcasereports
          BMJ Case Reports
          BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
          1757-790X
          2017
          1 November 2017
          : 2017
          : bcr2017222268
          Affiliations
          [1] departmentDepartment of Cardiology , Japan Community Healthcare Organization (JCHO), Osaka Hospital , Osaka, Japan
          Author notes
          [Correspondence to ] Dr Yoh Arita, arita-yo@ 123456osaka.jcho.go.jp
          Article
          PMC5695360 PMC5695360 5695360 bcr-2017-222268
          10.1136/bcr-2017-222268
          5695360
          29092973
          3f781588-c67f-4b2f-bb4a-f26832a3a18b
          © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
          History
          : 13 October 2017
          Categories
          Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
          1522
          Case Report

          adult intensive care,cardiovascular system,arrhythmias

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content789

          Cited by6